Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality.
Steven D NathanShilpa JohriJoanna M JolyChristopher S KingAmresh RainaColleen A McEvoyDasom LeeEric ShenPeter SmithChunqin DengAaron B WaxmanPublished in: Thorax (2023)
Two independent modelling techniques that have been employed in the oncology literature both suggest a long-term survival benefit associated with inhaled treprostinil treatment in patients with PH-ILD.